UPP2
Basic information
Region (hg38): 2:157876679-158136154
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UPP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 19 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 20 | 5 | 2 |
Variants in UPP2
This is a list of pathogenic ClinVar variants found in the UPP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-158102053-T-C | not specified | Uncertain significance (Mar 20, 2023) | ||
2-158102068-C-G | not specified | Uncertain significance (Nov 10, 2022) | ||
2-158102071-C-T | not specified | Uncertain significance (Jan 19, 2024) | ||
2-158102092-G-A | not specified | Likely benign (Dec 15, 2023) | ||
2-158106115-G-A | not specified | Uncertain significance (Sep 25, 2023) | ||
2-158115113-G-A | not specified | Uncertain significance (Apr 17, 2023) | ||
2-158115152-A-C | Benign (Dec 31, 2019) | |||
2-158115161-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
2-158115162-A-G | not specified | Uncertain significance (Aug 28, 2023) | ||
2-158115167-G-A | not specified | Likely benign (Jun 03, 2022) | ||
2-158115173-G-C | not specified | Uncertain significance (Feb 05, 2024) | ||
2-158115228-T-C | not specified | Uncertain significance (May 14, 2024) | ||
2-158117890-C-T | not specified | Uncertain significance (Feb 10, 2022) | ||
2-158117920-G-A | not specified | Uncertain significance (Mar 31, 2023) | ||
2-158117921-G-C | not specified | Uncertain significance (Feb 28, 2024) | ||
2-158121416-A-C | Benign (Jan 25, 2018) | |||
2-158121469-G-A | not specified | Likely benign (Apr 17, 2023) | ||
2-158121494-C-G | not specified | Uncertain significance (Sep 22, 2023) | ||
2-158121548-C-A | not specified | Uncertain significance (Nov 15, 2021) | ||
2-158121597-T-C | not specified | Uncertain significance (Jul 09, 2021) | ||
2-158123758-G-T | not specified | Uncertain significance (Jul 27, 2021) | ||
2-158123842-T-C | not specified | Uncertain significance (May 27, 2022) | ||
2-158123893-A-G | not specified | Uncertain significance (Jun 17, 2022) | ||
2-158134766-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
2-158134805-C-T | not specified | Uncertain significance (Sep 29, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UPP2 | protein_coding | protein_coding | ENST00000605860 | 9 | 259453 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00126 | 0.963 | 110916 | 1095 | 13730 | 125741 | 0.0608 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.378 | 193 | 208 | 0.926 | 0.0000109 | 2457 |
Missense in Polyphen | 52 | 60.331 | 0.86192 | 760 | ||
Synonymous | 0.465 | 70 | 75.1 | 0.932 | 0.00000402 | 723 |
Loss of Function | 1.85 | 7 | 14.7 | 0.477 | 7.83e-7 | 200 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.298 | 0.294 |
Ashkenazi Jewish | 0.0727 | 0.0723 |
East Asian | 0.133 | 0.132 |
Finnish | 0.0188 | 0.0188 |
European (Non-Finnish) | 0.0304 | 0.0301 |
Middle Eastern | 0.133 | 0.132 |
South Asian | 0.109 | 0.105 |
Other | 0.0506 | 0.0493 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the reversible phosphorylytic cleavage of uridine and deoxyuridine to uracil and ribose- or deoxyribose-1- phosphate. The produced molecules are then utilized as carbon and energy sources or in the rescue of pyrimidine bases for nucleotide synthesis. Shows substrate specificity and accept uridine, deoxyuridine, and thymidine as well as the two pyrimidine nucleoside analogs 5-fluorouridine and 5-fluoro-2(')-deoxyuridine as substrates.;
- Pathway
- Pyrimidine metabolism - Homo sapiens (human);Drug metabolism - other enzymes - Homo sapiens (human);Fluoropyrimidine Pathway, Pharmacokinetics;Pyrimidine Metabolism;UMP Synthase Deiciency (Orotic Aciduria);MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy);Beta Ureidopropionase Deficiency;Dihydropyrimidinase Deficiency;Fluoropyrimidine Activity;pyrimidine ribonucleosides degradation;pyrimidine deoxyribonucleosides degradation;Pyrimidine catabolism;Nucleobase catabolism;Metabolism of nucleotides;Metabolism;Pyrimidine salvage;Nucleotide salvage;Pyrimidine metabolism;pyrimidine ribonucleosides degradation
(Consensus)
Recessive Scores
- pRec
- 0.147
Intolerance Scores
- loftool
- 0.408
- rvis_EVS
- -0.11
- rvis_percentile_EVS
- 45.26
Haploinsufficiency Scores
- pHI
- 0.117
- hipred
- N
- hipred_score
- 0.219
- ghis
- 0.550
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.935
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Upp2
- Phenotype
Gene ontology
- Biological process
- nucleoside metabolic process;nucleotide catabolic process;pyrimidine nucleoside salvage;UMP salvage;uridine metabolic process;pyrimidine nucleoside catabolic process
- Cellular component
- cytosol;type III intermediate filament
- Molecular function
- uridine phosphorylase activity;protein binding